Sign Up to like & get
recommendations!
2
Published in 2023 at "Expert Opinion on Investigational Drugs"
DOI: 10.1080/13543784.2023.2199919
Abstract: ABSTRACT Introduction JAK (Janus kinase) is a type of non-receptor tyrosine kinase that includes JAK1, JAK2, JAK3, and Tyk2. Currently, there are five JAK inhibitors approved for treating rheumatoid arthritis. These inhibitors vary in their…
read more here.
Keywords:
jak inhibitors;
inhibitors rheumatoid;
rheumatoid arthritis;
jak ... See more keywords